Biotech Values

[mcbio]

Re: AIS

Quote:
--------------------------------------------------------------------------------
I've been a long-time investor in AIS & think it has a lot of potential to move higher. Partnership possibilities for Libigel, Anturol, Nestorone, and their methotrexate injector could all add substantial value.
--------------------------------------------------------------------------------

AIS does have a lot of irons in the fire. However, standalone drug-delivery companies rarely pull in large profits because drug-delivery technology is a widely available commodity and is priced accordingly in the marketplace. A drug-delivery company has to have a stake of a singularly exciting product such as LibiGel to be worthy of investing, IMO.

So you're saying that AIS could be worthy of investing in given its link to LibiGel, correct?